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Measurement of abnormal bone composition
in vivo using noninvasive Raman spectroscopy
Kevin Buckley1,2, Jemma G Kerns2, Panagiotis D Gikas2,3, Helen L Birch2, Jacqueline Vinton3,
Richard Keen3, Anthony W Parker1,2, Pavel Matousek1,2 and Allen E Goodship2
1Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, Harwell Oxford, UK. 2UCL
Institute ofOrthopaedics andMusculoskeletal Science, London,UK. 3Royal NationalOrthopaedicHospital, Stanmore,UK.
X-ray-based diagnostic techniques, which are by far themost widely used for diagnosing bone disorders and diseases,
are largely blind to the protein component of bone. Bone proteins are important because they determine certain
mechanical properties of bone and changes in the proteins have been associated with a number of bone diseases.
Spatially Offset Raman Spectroscopy (SORS) is a chemically specific analytical technique that can be used to retrieve
information noninvasively from both the mineral and protein phases of the bone material in vivo. Here we demonstrate
that SORS can be used to detect a known compositional abnormality in the bones of a patient suffering from the genetic
bone disorder, osteogenesis imperfecta, a condition which affects collagen. The confirmation of the principle that bone
diseases in living patients can be detected noninvasively using SORS points the way to larger studies that focus on
osteoporosis and other chronic debilitating bone diseases with large socioeconomic burdens.
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Introduction
Musculoskeletal diseases have a large and growing socio-
economic cost in countries with ageing populations; for
example, in the UK there are over 70 000 hip fractures asso-
ciated with osteoporosis and over 70 000 primary hip repla-
cements associated with osteoarthritis annually.1,2 Presently,
the range of clinical tools for early detection of these diseases is
limited. In the case of osteoporosis, populations at higher risk of
a first fragility fracture are identified using an association with
bone density; however, the sensitivity of this method for an
individual patient is o40%.3 Osteoarthritic patients usually
seek treatment when they feel pain, at which point much of the
affected joint can already be damaged or destroyed. The
development of new screening and/or diagnostic tools for
musculoskeletal diseases with higher sensitivity would enable
earlier detection and treatments and could lead to a reduction in
serious and costly clinical events. In the present study, we
assess Spatially Offset Raman Spectroscopy (SORS), a variant
ofRamanspectroscopy that allows the retrieval of rich chemical
information from a target layer through a turbid medium,4,5 as a
bone-disease detection tool.
Osteogenesis imperfecta (OI) is a class of genetic disorders in
which mutations in the collagen genes, or mutations in the
genes associated with collagen (for example, those associated
with collagen post-translational modifications), affect the
performance of the skeleton. As there are hundreds of
mutations associated with OI, there are hundreds of pheno-
typical manifestations.6,7 Some of these mutations affect the
skeleton sobadly that they result in death in uteroor shortly after
birth (corresponding to type II in theSillence classification ofOI).
Other mutations severely affect the skeleton and result in
multiple fractures and short stature (roughly corresponding to
type III and type IV in the same classification system). The
mildest phenotypical manifestations (roughly corresponding to
type I) can weaken the bones but in some cases are difficult to
diagnose using X-ray-based techniques.
Patient Characteristics
The patient was a 26-year-old female with type IV OI. She had
previously received treatment with Risedronate for 14 years,
although this treatment was discontinued in November 2011
followinga fracture to the femur. Thepatient underwent awedge
osteotomy in order to straighten her femur in February 2012 at
the Royal National Orthopaedic Hospital and donated (with
appropriate consent and ethical approvals) a section of bone
thatwasB0.5 cm thickat oneendand tapered to0.1mm. Itwas
cut from the mid-shaft of the femur.
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Determining the compositional abnormality of the patient’s
bone
The section of excised OI bone was probed with Raman
spectroscopy and compared with non-OI bone that was
excised (with appropriate ethical approvals) from the cadaveric
tibiae of another female (aged 72 years). The Raman data were
collected from the two excised sections with an inVia Raman
microscope (Renishaw plc., Gloucestershire, UK) equipped
with an 830nm 200mW laser (B10mW at the sample). Twelve
1min (60 1 s) spectra were collected from each excised
sample and averaged. It was found that the OI patient’s bone
was significantly more mineralised compared with non-OI
control bone; specifically, the phosphate n1 to Amide III ratio
was B11% higher (Figure 1a). The probing with Raman
spectroscopy did not require any sample preparation; the laser
was simply directed onto fresh bone samples.
Transcutaneous in vivo measurement
TheOIpatient returned to the hospital 10months after her femur
operation and her bones were scanned, transcutaneously, with
a custom-built SORS instrument which utilised an 830nm,
300mW laser (Cobalt Light Systems, Oxfordshire, UK). The
data were collected using the inverse SORS geometry––that is,
an annular laser beam with the Raman collection point at the
centre of the ring.8 The laser power in the ring was capped at
30mW per 3.5mm diameter aperture (as per BS EN 60825-
1:2007, the safety standard relevant to laser light on the skin).
The power automatically increased with increasing illumination
area but stayed within the safety limit (BS EN 60825-1:2007).
Spectra were collected from phalanges in the hands (five 0mm
offset, one 2.5mm offset and six 5mm offset spectra) and from
the tibiae (one 0mm offset and three 8mm offset, collected at
the midpoint of the bone). The accumulation time for each
spectrum was 60 s (60 1 s); hence, in total 16min data were
collected. The OI patient’s DEXA Z-scores at the time of the
SORS scans were  1.7,  2.5 and  2.3 at her left hip, spine
and right forearm, respectively. Control (non-OI) data were
collected from a 20.5-year-old female volunteer using the same
protocol.
Processing of transcutaneous in vivo data
The 32 Raman spectra were corrected for the charge-coupled
detector’s varying sensitivity across the spectra range and the
broad fluorescencewas removed fromeach spectrumby fitting
a fourth order polynomial from 735 to 1540 cm 1.9 The spectra
were then normalised to the lipid band at B1303cm 1.
In order to remove the surface signals (that is, from the skin
and lipid layers), the spectra were decomposed using Band
Target Entropy Minimisation (BTEM).10,11 The BTEM decom-
position was repeated 15 times for the patient and 15 times for
the control (that is, the whole-data set, with one spectrum left
out in turn, was analysed for each individual); the algorithmwas
applied to sections of each spectrum (735–1384cm 1) and to
the dominant phosphate band (955–970 cm 1); fifteen
eigenvectors were used. The 15 resultant spectra were
averaged and s.d. calculated.
The SORS spectra show that, as expected from the excised
measurements, the bone of the OI patient is more mineralised
compared with the bone from the age-matched control;
specifically, themineral-to-protein ratio (phosphate n1 to amide
III ratio) of the OI patient’s bone is B14% higher than that
of the control bone (Figure 1b).
Discussion
SORS has been used to detect bone compositional
abnormalities in an OI patient whose bones are known to have
an increased ratio of mineral to protein (from excised
Figure 1 (a) A Raman spectrum of excised OI bone (black) and excised control bone (red). The inset shows mean±s.d. (b) A spatially offset Raman spectrum retrieved
noninvasively through the skin of the same OI patient (black) and a spatially offset Raman spectrum retrieved noninvasively through the skin of an age-matched control (red).
The inset shows mean±s.d.
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examination). It is the first time a human bone disease has been
detected with the technique in vivo.
Although OI is relatively rare, the demonstration that it
can be detected with SORS in a clinical setting is nonetheless
significant. The bone density of patients with some forms
of OI can be normal, and, because X-ray-based diagnostic
techniques cannot resolve the protein component of bone,
these conditions can be very difficult to diagnose, especially in
children. There have been cases where the authorities
have mistakenly ascribed repeated bone fractures to child
abuse, when the child in question was in fact an undiagnosed
sufferer of mild OI.
The demonstration that SORS can detect a compositional
abnormality noninvasively points the way to studies of bone
diseases that have large societal impacts. For example, it is
known from studies of excised specimens of bone that women
with and without osteoporotic fracture have bone composi-
tional differences that can be detected with Raman spectro-
scopy.12 A technique that allowed the monitoring of these
compositional differences in vivo could improve clinicians’
ability to predict fractures and enable management strategies
that would enhance subsequent quality of life.
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